Technical Analysis for CLSN - Celsion Corporation

Grade Last Price % Change Price Change
grade D 1.74 1.75% 0.03
CLSN closed up 1.75 percent on Friday, September 13, 2019, on 1.25 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CLSN trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Touch Weakness 1.75%
Oversold Stochastic Weakness 1.75%
20 DMA Resistance Bearish 1.75%
Fell Below 50 DMA Bearish 1.75%
MACD Bearish Centerline Cross Bearish 1.75%
Expansion Pivot Sell Setup Bearish Swing Setup 1.75%

Older signals for CLSN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company develops ThermoDox, a liposomal encapsulation of doxorubicin, which is under Phase III clinical trial for primary liver cancer; under phase II clinical trial for colorectal liver metastasis; and under phase II clinical trial for treatment of recurrent chest wall breast cancer. It has a development, product supply, and commercialization agreement with Yakult Honsha Co. for ThermoDox; and a joint research agreement with Royal Philips Electronics to evaluate the combination of Philips' high intensity focused ultrasound with its ThermoDox to determine the potential of this combination to treat various cancers. The company was founded in 1982 and is based in Lawrenceville, New Jersey.
Medicine Cancer Clinical Medicine Cancers Chemotherapy Ultrasound Antineoplastic Drugs Drug Development Hepatology Hepatocellular Carcinoma Anthracyclines Doxorubicin High Intensity Focused Ultrasound
Is CLSN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.88
52 Week Low 1.35
Average Volume 83,948
200-Day Moving Average 1.9739
50-Day Moving Average 1.7672
20-Day Moving Average 1.8025
10-Day Moving Average 1.773
Average True Range 0.0784
ADX 13.56
+DI 14.1933
-DI 20.4245
Chandelier Exit (Long, 3 ATRs ) 1.6648
Chandelier Exit (Short, 3 ATRs ) 1.8392
Upper Bollinger Band 1.9058
Lower Bollinger Band 1.6992
Percent B (%b) 0.2
BandWidth 11.461859
MACD Line -0.0098
MACD Signal Line 0.0014
MACD Histogram -0.0112
Fundamentals Value
Market Cap 14.53 Million
Num Shares 8.35 Million
EPS -5.58
Price-to-Earnings (P/E) Ratio -0.31
Price-to-Sales 47.77
Price-to-Book 2.54
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.85
Resistance 3 (R3) 1.84 1.80 1.83
Resistance 2 (R2) 1.80 1.77 1.80 1.82
Resistance 1 (R1) 1.77 1.76 1.79 1.78 1.82
Pivot Point 1.73 1.73 1.74 1.73 1.73
Support 1 (S1) 1.70 1.70 1.72 1.71 1.66
Support 2 (S2) 1.66 1.69 1.66 1.66
Support 3 (S3) 1.63 1.66 1.65
Support 4 (S4) 1.64